Back to search
FDAFDA · Food and drugs·Recall number D-1496-2022

Sodium Chloride Ophthalmic Ointment USP, 5%, Sterile, Net Wt 3.5 g (1/8 oz) tube, Mfg by: Akorn, Inc., Lake Forest , IL 600405, NDC 17478-622-35

Published September 14, 2022 · Recall initiated: August 31, 2022

Summary

FDA records drug Class II recall D-1496-2022, published September 14, 2022 and initiated August 31, 2022. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 48,636 tubes; Lot: Lot#: 9J58A, 9J58B, Exp 8/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
USA nationwide
Lot
Lot#: 9J58A, 9J58B, Exp 8/31/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sodium Chloride Ophthalmic Ointment USP, 5%, Sterile, Net Wt 3.5 g (1/8 oz) tube, Mfg by: Akorn, Inc., Lake Forest , IL 600405, NDC 17478-622-35 recalled?

Yes. FDA published recall D-1496-2022 on September 14, 2022. Reported hazard: cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

What should I do if I have this product?

Voluntary: Firm initiated · Letter